↓ Skip to main content

Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer

Overview of attention for article published in Frontiers in oncology, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
135 Dimensions

Readers on

mendeley
119 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
Published in
Frontiers in oncology, January 2013
DOI 10.3389/fonc.2013.00049
Pubmed ID
Authors

Yana G. Najjar, James H. Finke

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
United States 2 2%
Sweden 1 <1%
Japan 1 <1%
United Kingdom 1 <1%
Unknown 112 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 24%
Student > Ph. D. Student 27 23%
Other 13 11%
Student > Master 12 10%
Student > Bachelor 9 8%
Other 20 17%
Unknown 10 8%
Readers by discipline Count As %
Medicine and Dentistry 33 28%
Agricultural and Biological Sciences 33 28%
Immunology and Microbiology 18 15%
Biochemistry, Genetics and Molecular Biology 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 9 8%
Unknown 15 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2013.
All research outputs
#23,391,126
of 26,017,215 outputs
Outputs from Frontiers in oncology
#16,292
of 22,782 outputs
Outputs of similar age
#265,421
of 295,070 outputs
Outputs of similar age from Frontiers in oncology
#196
of 329 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,782 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,070 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 329 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.